Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 1 (1)

Trial Status

Unknown2
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07328243Not ApplicableRecruitingPrimary

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study

NCT01471288Phase 1UnknownPrimary

Effect of Carum Carvi on Thyroid Hormones and TSH Level

NCT00822289Unknown

The Effect of Radioactive Iodine Administration for Thyroid Diseases on H.Pylori Eradication

Showing all 3 trials

Research Network

Activity Timeline